---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042912"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T09:33:00.696504+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Aspira Women's Health presents pipeline status overview; no specific data in filing

## Summary
- Slide deck provided on October 29, 2024 covers product pipeline but full content is not included in the 8-K.
- No financial figures, clinical results, or timeline updates are disclosed in the filing body.
- Investors need to refer to the separate slide deck for pipeline details; no material metrics available here.

## SEC filing metadata
- accession: 0001493152-24-042912
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000149315224042912/0001493152-24-042912-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000149315224042912/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042912
- JSON: https://secwatch.observer/filing/0001493152-24-042912.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042912.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.